Loss of cyclin-dependent kinase-like 2 predicts poor prognosis in gastric cancer, and its overexpression suppresses cells growth and invasion

doi:10.1002/cam4.1577

CNU IR > Pharmacy and Science > Dept. of Health and Nutrition (including master's program) > Periodical Articles > Item 310902800/32308

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/32308

题名:	Loss of cyclin-dependent kinase-like 2 predicts poor prognosis in gastric cancer, and its overexpression suppresses cells growth and invasion
作者:	Fang, Chia-Lang Uen, Yih-Huei Chen, Han-Kun Hseu, You-Cheng Lin, Chih-Chan Hung, Shih-Ting Sun, Ding-Ping Lin, Kai-Yuan
贡献者:	Taipei Med Univ, Coll Med, Sch Med, Dept Pathol Taipei Med Univ, Wan Fang Hosp, Dept Pathol Asia Univ Hosp, Dept Surg Chi Mei Med Ctr, Dept Surg China Med Univ, Dept Cosmeceut Asia Univ, Dept Hlth & Nutr Biotechnol Chi Mei Med Ctr, Dept Med Res Chia Nan Univ Pharm & Sci, Dept Nutr Chia Nan Univ Pharm & Sci, Dept Biotechnol
关键词:	CDKL2 gastric cancer immunohistochemistry prognosis
日期:	2018-07
上传时间:	2019-11-15 15:49:00 (UTC+8)
出版者:	WILEY
摘要:	Cyclin-dependent kinase-like 2 (CDKL2), a new member of the cyclin-dependent kinase family, may be involved in gastric cancer (GC) progression. Thus, we conducted this study to explore the clinical effect of CDKL2 in GC. Immunohistochemistry was used to measure CDKL2 levels in gastric tissues. The association of a high CDKL2 level with clinical and pathological characteristics, and the correlation between the CDKL2 level and disease-free and overall survival were analyzed. Transfection was employed to overexpress CDKL2 in GC cells and to investigate the effect of CDKL2 overexpression on cell proliferation and invasion. Loss of CDKL2 was positively correlated with several clinical and pathological characteristics, and patients with a low CDKL2 level had significantly poorer disease-free and overall survival than those with a high level (P=.005 and .001, respectively). Univariate analysis using the Cox proportional hazards model indicated that a low CDKL2 level was a prognosticator for inferior disease-free survival (P=.007). Based on immmunoblotting data, AGS and HGC-27 GC cells were chosen for CDKL2 overexpression. Cellular studies revealed that CDKL2 overexpression impaired cell proliferation and invasion. Loss of CDKL2 may serve as a biomarker for predicting GC patient outcomes and a potential therapeutic target for GC treatment.
???metadata.dc.relation.uri???:	http://dx.doi.org/10.1002/cam4.1577
關聯:	Indian Journal of Pharmaceutical Sciences, v.7, n.7, pp.2993-3002
显示于类别:	[Dept. of Health and Nutrition (including master's program)] Periodical Articles [Dept. of Biotechnology (including master's program)] Periodical Articles

文件中的档案:

档案	描述	大小	格式	浏览次数
10.1002-cam4.1577.pdf		749Kb	Adobe PDF	498	检视/开启
index.html		0Kb	HTML	1380	检视/开启

在CNU IR中所有的数据项都受到原著作权保护.

TAIR相关文章

数据加载中.....